Published: Feb, 2018
The world pharmerging market is poised to experience substantial rise, particularly in the developing economies across the globe. The prevalence of escalating income, free trade agreement, increased expectancy of life, expanding base of aging population, non-communicable diseases, increased healthcare expenditure by the government are all expected to boost the market. Furthermore, relentless research and development is also one of the prime factors that have been shaping the market trajectory in the years to come.
As mentioned in the market research report that has been recently published by Transparency Market Research, an intensely competitive vendor landscape is expected to greet the new entrants and market aspirants into the world market for pharmerging. The said market’s competitive vendor landscape has been widely fragmented in nature till now. Many prominent names such as F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Johnson & Johnson and Novartis AG. These companies despite being the leading ones, these companies hold minor shares of the said market.
In accordance with the TMR report, the leading names that operate in the world market for pharmerging are presently emphasizing on obtaining larger shares via aggressive expansion strategies and product innovation. Acquisitions and mergers are becoming increasingly more of a commonplace in the international market for pharmerging as larger and eminent players continue to gain larger share of the market.
The research analysts have estimated that the world pharmerging market would rise at a highly optimistic growth rate of 11.30% during the period of forecast that extends from the year 2016 to 2024, due to numerous market drivers like the increased demand for various pharma products overall. The said market is anticipated to reach a market valuation of US$1.40 bn by the end of the year 2024, after being valued at US$552.80 mn in the year 2015.
Asia Pacific to Lead with the Highest Contribution of Revenue to the Market
Taking geography into consideration, the world market for pharmerging is classified into North America, Latin America, Europe, Middle East and Africa and Asia Pacific. With a share of around 53%, the region of Asia Pacific has led this said market in the year 2016. Market researchers predict that this geographical segment would remain on the top owing to increased investments for medical research, fast urbanization, and growing expiration of patent. China has emerged as the main market for this region.
Amongst various other regional markets pertaining to pharmerging, the regions of Latin America and Europe are willing to experience robust growth in the years to come. Extensive research and development practices, advancement in technology, and increased awareness about the management and treatment of healthcare facilities are very likely to drive the market in Latin America. The market in Europe is foreseen to be driven by the growing expenditure on healthcare in the region, increasing prevalence of diseases, and last but not the least the huge size of population is also expected to drive the market.
Increasing Healthcare Expenses to Encourage Market Growth
There are various factors that are driving the world market for pharmerging. In accordance with the said report by TMR, the world market for pharmerging is at present needing to depend heavily on substantial grants by various governments and investments in a bid to carry its efforts of development and research to the next very level. Whilst the soaring expenditure pertaining to the healthcare industry is surely benefitting the market players from the world market for pharmerging, they are being thrown into prominence via immense interest exhibited by many of the major governing bodies and governments.
The incentives and interventions by various government schemes allow various market players operating in the world market for pharmerging to come up with their products much faster, offer those products at a more affordable prices, and also to channel more focus on research and development work.
However, there is a flipside of the market too. The said market is expected to witness some restraints in its growth rate owing to factors like the weakening of economies, particularly from the region of Africa.
The information shared that ahs been in this review is based on a TMR report, titled, “Pharmerging Market (Product Type - Pharmaceuticals (Branded Prescription Drugs, Generic Drugs (Branded Generics, Unbranded Generics, and OTC Drugs) and Healthcare (Medical Devices, Diagnostic Instruments, and IT and Record Management); Economic Growth Levels - Tier - 1, Tier - 2, and Tier - 3; Indications - Lifestyle Diseases, Cancer and Autoimmune Diseases, and Infectious Diseases; Distribution Channel - Hospitals, Clinics, Retail Pharmacies, E-commerce, and Drug Stores) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024”
For the study the market has been segmented as follows:
Global Pharmerging Market Segmentation
- By Product
- Branded Prescription Drugs
- Generic Drugs
- Branded Generics
- Unbranded Generics
- OTC Drugs
- Medical Devices
- Diagnostic Instruments
- Others (IT and record management)
- By Indications
- Lifestyle Diseases
- Cancer and autoimmune diseases
- Infectious Diseases
- By Distribution Channel
- Retail Pharmacies
- Drug Stores
- By Region
- Asia Pacific
- Latin America
- Middle East and Africa
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact